{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:39:27Z","timestamp":1790854767582,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02492-2","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:42:30Z","timestamp":1730302950000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemia"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-3006","authenticated-orcid":false,"given":"Laura","family":"Dery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Rudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba Masri","family":"Iraqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odelia","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"1","key":"2492_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000497746","volume":"109","author":"L Vroonen","year":"2019","unstructured":"Vroonen L, Daly AF, Beckers A (2019) <ArticleTitle Language=\"En\">Epidemiology and management challenges in prolactinomas. Neuroendocrinology 109(1):20\u201327. https:\/\/doi.org\/10.1159\/000497746","journal-title":"Neuroendocrinology"},{"issue":"12","key":"2492_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2492_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","volume":"41","author":"T Mindermann","year":"1994","unstructured":"Mindermann T, Wilson CB (1994) Age-related and gender\u2010related occurrence of pituitary adenomas. Clin Endocrinol 41(3):359\u2013364. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02557.x","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2492_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","volume":"23","author":"A Colao","year":"2009","unstructured":"Colao A (2009) The prolactinoma. Best Pract Res Clin Endocrinol Metab 23(5):575\u2013596. https:\/\/doi.org\/10.1016\/j.beem.2009.05.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2492_CR5","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab 33(2):101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2492_CR6","doi-asserted-by":"publisher","unstructured":"Wildemberg LE, Fialho C, Gadelha MR, Prolactinomas (2021) Presse Med 50(4):104080. https:\/\/doi.org\/10.1016\/j.lpm.2021.104080","DOI":"10.1016\/j.lpm.2021.104080"},{"issue":"9","key":"2492_CR7","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","volume":"108","author":"RS Auriemma","year":"2023","unstructured":"Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R (2023) Approach to the Patient with Prolactinoma. J Clin Endocrinol Metab 108(9):2400\u20132423. https:\/\/doi.org\/10.1210\/clinem\/dgad174","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2492_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2492_CR9","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1038\/s41598-021-89256-7","volume":"11","author":"BM Leca","year":"2021","unstructured":"Leca BM, Mytilinaiou M, Tsoli M, Epure A, Aylwin SJ, Kaltsas G, Randeva HS, Dimitriadis GK (2021) Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis. Sci Rep 11(1):9801. https:\/\/doi.org\/10.1038\/s41598-021-89256-7","journal-title":"Sci Rep"},{"key":"2492_CR10","doi-asserted-by":"publisher","first-page":"910978","DOI":"10.3389\/fendo.2022.910978","volume":"13","author":"LA Schuler","year":"2022","unstructured":"Schuler LA, O\u2019Leary KA (2022) Prolactin: the third hormone in breast cancer. Front Endocrinol 13:910978. https:\/\/doi.org\/10.3389\/fendo.2022.910978","journal-title":"Front Endocrinol"},{"issue":"10","key":"2492_CR11","doi-asserted-by":"publisher","first-page":"bqac122","DOI":"10.1210\/endocr\/bqac122","volume":"163","author":"CV Clevenger","year":"2022","unstructured":"Clevenger CV, Rui H (2022) Breast cancer and prolactin\u2013new mechanisms and models. Endocrinol 163(10):bqac122. https:\/\/doi.org\/10.1210\/endocr\/bqac122","journal-title":"Endocrinol"},{"key":"2492_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00309236","volume":"23","author":"S Haga","year":"1993","unstructured":"Haga S, Watanabe O, Shimizu T, Iida T, Imamura H, Kajiwara T, Fujibayashi M (1993) Breast cancer in a male patient with prolactinoma. Surg Today 23:251\u2013255. https:\/\/doi.org\/10.1007\/BF00309236","journal-title":"Surg Today"},{"issue":"3","key":"2492_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/00313029700169205","volume":"29","author":"I Strungs","year":"1997","unstructured":"Strungs I, Gray RA, Rigby HB, Strutton G (1997) Two case reports of breast carcinoma associated with prolactinoma. Pathol 29(3):320\u2013323. https:\/\/doi.org\/10.1080\/00313029700169205","journal-title":"Pathol"},{"issue":"1","key":"2492_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W","volume":"64","author":"MD Volm","year":"1997","unstructured":"Volm MD, Talamonti MS, Thangavelu M, Gradishar WJ (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64(1):74\u201378. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/(SICI)1096-9098(199701)64:1%3C74::AID-JSO14%3E3.0.CO;2-W","journal-title":"J Surg Oncol"},{"key":"2492_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/BF03351047","volume":"24","author":"F Forloni","year":"2001","unstructured":"Forloni F, Giovilli M, Pecis C, Bortolani E, Preziosi A, Barzaghi ME, Corti D, Beck-Peccoz P (2001) Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. J Endocrinol Invest 24:454\u2013459. https:\/\/doi.org\/10.1007\/BF03351047","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2492_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2325\/jbcs.14.302","volume":"14","author":"T Sato","year":"2007","unstructured":"Sato T, Muto I, Hasegawa M, Aono T, Okada T, Tamura T, Sakai T (2007) A rare case of invasive ductal carcinoma with hyperprolactinemia. Breast Cancer 14(3):302\u2013306. https:\/\/doi.org\/10.2325\/jbcs.14.302","journal-title":"Breast Cancer"},{"key":"2492_CR17","doi-asserted-by":"publisher","first-page":"bcr0120091421","DOI":"10.1136\/bcr.01.2009.1421","volume":"2011","author":"CM Mallawaarachchi","year":"2011","unstructured":"Mallawaarachchi CM, Ivanova S, Shorthouse A, Shousha S, Sinnett D (2011) A rare case of male breast ductal carcinoma in-situ associated with prolactinoma. BMJ Case Rep 2011:bcr0120091421. https:\/\/doi.org\/10.1136\/bcr.01.2009.1421","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2492_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15384047.2017.1294284","volume":"18","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Mo W, Yu Y, Zou D, He X, Xia X, Hu J (2017) Breast carcinoma associated with prolactinoma: A case report. Cancer Biol Ther 18(3):132\u2013136. https:\/\/doi.org\/10.1080\/15384047.2017.1294284","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"2492_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4048\/jbc.2020.23.e63","volume":"23","author":"S Hao","year":"2020","unstructured":"Hao S, Huang M, Tian W, Chen Y, Zhao J, Luo D (2020) Whole exome sequencing in the male breast cancer with prolactinoma: a case report and literature review. J Breast Cancer 23(6):656\u2013664. https:\/\/doi.org\/10.4048\/jbc.2020.23.e63","journal-title":"J Breast Cancer"},{"key":"2492_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-009-0214-y","volume":"13","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Romijn JA, De Boer A, Vandenbroucke JP (2010) The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary 13:195\u2013198. https:\/\/doi.org\/10.1007\/s11102-009-0214-y","journal-title":"Pituitary"},{"issue":"2","key":"2492_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/EJE-11-0076","volume":"165","author":"K Berinder","year":"2011","unstructured":"Berinder K, Akre O, Granath F, Hulting AL (2011) Cancer risk in hyperprolactinemia patients: a population-based cohort study. Eur J Endocrinol 165(2):209\u2013215. https:\/\/doi.org\/10.1530\/EJE-11-0076","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2492_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-15-0282","volume":"173","author":"OM Dekkers","year":"2015","unstructured":"Dekkers OM, Ehrenstein V, Bengtsen M, Farkas DK, Pereira AM, S\u00f8rensen HT, J\u00f8rgensen JO (2015) Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature. Eur J Endocrinol 173(2):269\u2013273. https:\/\/doi.org\/10.1530\/EJE-15-0282","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"2492_CR23","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","volume":"73","author":"SS Tworoger","year":"2013","unstructured":"Tworoger SS, Eliassen AH, Zhang X, Qian J, Sluss PM, Rosner BA, Hankinson SE (2013) A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res 73(15):4810\u20134819. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0665","journal-title":"Cancer Res"},{"issue":"18","key":"2492_CR24","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","volume":"64","author":"SS Tworoger","year":"2004","unstructured":"Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64(18):6814\u20136819. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1870","journal-title":"Cancer Res"},{"issue":"5","key":"2492_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/09513590.2022.2047173","volume":"38","author":"AF Aranha","year":"2022","unstructured":"Aranha AF, Dos Anjos LG, Turri JA, Simoes RS, Maciel GA, Baracat EC, Soares-Junior JM, Carvalho KC (2022) Impact of the prolactin levels in breast cancer: a systematic review and meta-analysis. Gynecol Endocrinol 38(5):385\u2013390. https:\/\/doi.org\/10.1080\/09513590.2022.2047173","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2492_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","volume":"49","author":"V Popovic","year":"1998","unstructured":"Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J (1998) Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol 49(4):441\u2013445. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00536.x","journal-title":"Clin Endocrinol"},{"issue":"10","key":"2492_CR27","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/cancers14102569","volume":"14","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Nowak AZ, Romanowicz H (2022) Breast cancer\u2014epidemiology, classification, pathogenesis and treatment (review of literature). Cancers 14(10):2569. https:\/\/doi.org\/10.3390\/cancers14102569","journal-title":"Cancers"},{"issue":"6","key":"2492_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1158\/1055-9965.EPI-20-1297","volume":"30","author":"ME Sehl","year":"2021","unstructured":"Sehl ME, Henry JE, Storniolo AM, Horvath S, Ganz PA (2021) The effects of lifetime estrogen exposure on breast epigenetic age. Cancer Epidemiol Biomarkers Prev 30(6):1241\u20131249. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1297","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2492_CR29","doi-asserted-by":"publisher","unstructured":"Santen RJ, Yue W, Wang JP (2015) Estrogen metabolites and breast cancer. Steroids 99:61\u2013\u20096. https:\/\/doi.org\/10.1016\/j.steroids.2014.08.003","DOI":"10.1016\/j.steroids.2014.08.003"},{"issue":"1","key":"2492_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.taap.2008.06.007","volume":"232","author":"SM Mense","year":"2008","unstructured":"Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, Hei TK, Bhat H (2008) Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 232(1):78\u201385. https:\/\/doi.org\/10.1016\/j.taap.2008.06.007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2492_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","volume":"37","author":"T Mancini","year":"2008","unstructured":"Mancini T, Casanueva FF, Giustina A (2008) Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 37(1):67\u201399. https:\/\/doi.org\/10.1016\/j.ecl.2007.10.013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"18","key":"2492_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/eurheartj\/ehs233","volume":"35","author":"R Haring","year":"2014","unstructured":"Haring R, Friedrich N, V\u00f6lzke H, Vasan RS, Felix SB, D\u00f6rr M, Meyer zu Schwabedissen HE, Nauck M, Wallaschofski H (2014) Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality. Eur Heart J 35(18):1215\u20131221. https:\/\/doi.org\/10.1093\/eurheartj\/ehs233","journal-title":"Eur Heart J"},{"issue":"4","key":"2492_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","volume":"31","author":"Y Macotela","year":"2020","unstructured":"Macotela Y, Triebel J, Clapp C (2020) Time for a new perspective on prolactin in metabolism. Trends Endocrinol Metab 31(4):276\u2013286. https:\/\/doi.org\/10.1016\/j.tem.2020.01.004","journal-title":"Trends Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02492-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02492-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02492-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:28:23Z","timestamp":1740997703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02492-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2492"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02492-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any financial or personal relationships with other people or organizations to disclose.\u00a0The institutional ethics committee did not require written informed consent since data were collected anonymously, with no active participation of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}